Elevated Creatine Kinase Levels With Second-Generation Antipsychotics

被引：3
|
作者：
Agarkar, Smita [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, Dept Psychiat, White Plains, NY USA
来源：
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES | 2011年 / 23卷 / 03期
关键词：
SERUM; PSYCHOSIS;
D O I：
10.1176/appi.neuropsych.23.3.E49
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E49 / E50
页数：2
相关论文
共 50 条
  • [31] Second-generation antipsychotics in treating bipolar disorder
    Gentile, Salvatore
    SALUD I CIENCIA, 2010, 17 (04): : 325 - 329
  • [32] Dominance of second-generation antipsychotics - time for reflection?
    Underwood, Benjamin R.
    PSYCHIATRIC BULLETIN, 2007, 31 (06): : 233 - 233
  • [33] Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
    Divac, Nevena
    Prostran, Milica
    Jakovcevski, Igor
    Cerovac, Natasa
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [34] Are Second-Generation Antipsychotics Useful in Tardive Dystonia?
    Pinninti, Narsimha Reddy
    Faden, Justin
    Adityanjee, Adit
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (05) : 183 - 197
  • [35] Polypharmacy with Second-Generation Antipsychotics: A Review of Evidence
    Pandurangi, Anand K.
    Dalkilic, Alican
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (06) : 345 - 367
  • [36] Second-generation antipsychotics and constipation: A review of the literature
    De Hert, M.
    Hudyana, H.
    Dockx, L.
    Bernagie, C.
    Sweers, K.
    Tack, J.
    Leucht, S.
    Peuskens, J.
    EUROPEAN PSYCHIATRY, 2011, 26 (01) : 34 - 44
  • [37] Second-generation kinase inhibitors
    Klebl, BM
    Müller, G
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (05) : 975 - 993
  • [38] ELEVATED CREATINE-KINASE LEVELS
    PATTEE, G
    RINGEL, SP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (15): : 2004 - 2004
  • [39] Plasma levels of second-generation antipsychotics and clinical response in acute psychosis: A review of the literature
    Lopez, Leonardo V.
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2013, 147 (2-3) : 368 - 374
  • [40] Acylcarnitine levels in paranoid schizophrenia with metabolic syndrome during treatment of second-generation antipsychotics
    Mednova, I.
    Chernonosov, A.
    Kornetova, E.
    Koval, V.
    Ivanova, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S313 - S313
12345